Cytocentric measurement for regenerative medicine

Any Regenerative Medicine (RM) business requires reliably predictable cell and tissue products. Regulatory agencies expect control and documentation. However, laboratory tissue production is currently not predictable or well-controlled. Before conditions can be controlled to meet the needs of cells...

Full description

Bibliographic Details
Main Authors: Alicia D. Henn, Taci Pereira, Joshua Hunsberger, Kunal Mitra, Zohreh Izadifar, Sita Somara, Lisa Lindström, Thomas Forest Farb-Horch, Jake Boy, George F. Muschler, Steven R. Bauer, Randy Yerden
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Medical Technology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmedt.2023.1154653/full